Product Image

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
4.8
★ ★ ★ ★ ★
(2951 ratings)
EPA (Eicosapentaenoic Acid) 729 mg
Fish Oil 1326 mg
Omega-3 1100 mg
DHA 275 mg
Product Image
Score85
A concentrated, EPA-forward fish oil with strong active-dose disclosure, but limited information about source, freshness protection, and independent purity checks.
How scoring works
Quantity:60 Softgel(s) • (60 servings)
Goals:
Heart Health
Cardiovascular Support
Anti-Inflammatory Support
Vision Support
Metabolism Boost
Joint Health
Skin Health
Mental Focus

Score 85

A concentrated, EPA-forward fish oil with strong active-dose disclosure, but limited information about source, freshness protection, and independent purity checks.
How scoring works

Also available as

1 option
120 servings DHA 275 mg, Fish Oil 1326 mg +2 more • 120 Softgel(s) • 120 servings $44.95 ($0.37 per serving)
$29.95($0.49 per serving)
Pure Formulas
$ 29.95
Vitacost
$ 29.95
iHerb
$ 29.95
Report prices

Analysis

A single softgel supplies 1,100 mg of total omega-3s, including 729 mg EPA and 275 mg DHA. The EPA-heavy balance is especially relevant to heart and inflammatory goals, while the DHA amount is less compelling for a DHA-focused use.

Molecular distillation adds useful processing information, and the active fats are listed separately. Fish species, molecular form, antioxidant protection, independent purity results, and the complete inactive-ingredient list remain unclear.

The 60-serving bottle suits someone trying the formula before committing to a larger package. Its serving value is good, although the companion 120-serving size is the more economical long-term choice.

Who is it for
  • Adults seeking a once-daily EPA-forward fish oil
  • People focused on heart or inflammatory support
Best for
  • High EPA intake in one softgel
  • Trying the formula in a smaller bottle

Pros

  • 1,100 mg total omega-3s per serving
  • EPA and DHA amounts are listed separately
  • Molecular distillation is disclosed

Cons

  • Fish species are not identified
  • No antioxidant stabilizer is listed
  • Larger companion bottle offers better serving value

Warnings

  • Avoid with a fish allergy because the oil is fish-derived
  • EPA and DHA can add to the effect of anticoagulant or antiplatelet medicines
  • Do not use capsules that smell strongly rancid because oxidation protection is not disclosed

Nutrient quality

93 Highest impact

Triglyceride delivery and high EPA plus DHA concentration provide strong nutrient quality. Missing antioxidant protection and independent purity verification temper confidence in freshness and contaminant control.

Ingredient transparency

81 Highest impact

Active fatty-acid quantities are clearly disclosed without a hidden blend. Missing full directions, excipients, and some oil-quality details reduce completeness.

Customer satisfaction

73 High impact

The supplied average rating is very strong and the rating volume is substantial. No specific experience details were provided to judge repeated complaints or purpose alignment.

Value for money

92 Highest impact

Formula quality and active-serving economics support strong practical value. It compares favorably within the category despite remaining disclosure gaps.

Report analysis

Goals

Heart Health
Heart Health
Impact
Highest effect
A+ Goal FitA+ Strength of SupportB+ CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 729 mg

A concentrated triglyceride fish oil provides strong cardiovascular support through clearly disclosed EPA and DHA. The combined amount is meaningful for lipid and inflammatory balance.

Molecular distillation and the triglyceride form strengthen quality and absorption confidence. The focused formula provides substantial depth without hiding the active fatty-acid yield behind a generic fish-oil total.

Study evidence
Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
A+ Goal FitA- Strength of SupportB- CoverageA+ Formula Quality
Fish Oil · 1326 mg

The concentrated fish oil supplies a meaningful amount of EPA and DHA for lipid and endothelial support. These fatty acids have strong human evidence for improving triglyceride levels, with broader cardiovascular effects depending on the user and dose.

Triglyceride form, molecular distillation, and separate EPA and DHA disclosure support quality and absorption. Independent testing, fish species, and antioxidant protection are not provided.

Study evidence
Fish Oil Supportive 185 studies
Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
Highest effect
A Goal FitA Strength of SupportC+ CoverageA Formula Quality
Fish Oil · 1326 mg

The triglyceride fish oil supplies just over one gram of EPA and DHA, giving strong support for inflammation-resolution pathways. High concentration and separate EPA and DHA disclosure strengthen confidence in the active dose.

Molecular distillation supports purity, but independent testing, fish species, sustainability details, and an antioxidant stabilizer are not shown. The focused single-softgel design still delivers substantial depth for this goal.

Study evidence
Fish Oil Supportive 68 studies
Vision Support
Vision Support
Impact
Highest effect
B+ Goal FitA+ Strength of SupportC- CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 729 mg

Natural astaxanthin provides targeted retinal antioxidant support and may help eye strain linked to prolonged screen use. Human evidence is promising for visual fatigue but less comprehensive than multi-nutrient macular formulas.

The algae source and substantial amount are clearly disclosed in a fat-containing softgel. The focused formula offers strong antioxidant depth but does not cover macular pigments, minerals, or omega fatty acids.

Metabolism Boost
Metabolism Boost
Impact
High effect
C Goal FitA Strength of SupportD+ CoverageA- Formula Quality
Omega-3 · 86 mg

EPA and DHA may support insulin sensitivity and metabolic health indirectly. Human evidence is useful for cardiometabolic markers, but omega-3 fats do not directly stimulate thermogenesis.

The 1100 mg total omega-3 amount, including 729 mg EPA and 275 mg DHA, provides a substantial dose. The triglyceride form and individual fatty-acid amounts support strong disclosure. The oil comes from fish and may not be suitable for people with a fish allergy.

Study evidence
Omega-3 Supportive 42 studies
Joint Health
Joint Health
Impact
High effect
C+ Goal FitB+ Strength of SupportD+ CoverageA+ Formula Quality
Omega-3 · 86 mg

Clearly disclosed EPA and DHA amounts provide a meaningful omega-3 dose that may support inflammatory balance and joint comfort. The product remains a focused lipid supplement rather than a complete joint formula.

It offers strong depth for one pathway but no cartilage building blocks or direct lubrication support. Transparent fatty-acid amounts and a streamlined design strengthen confidence in the intended use.

Study evidence
Omega-3 Supportive 40 studies

Ingredients

IngredientAmount per serving
Calories
15 Calorie(s)
Calories from Fat
10 Calorie(s)
Total Fat
1.5 Gram(s)
Molecularly distilled Fish Oil
1326 mg
Total Omega-3 Fatty Acids
1100 mg
Eicosapentaenoic Acid
729 mg
Docosahexaenoic Acid
275 mg
Other Omega-3 Fatty Acids
86 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
EPA (Eicosapentaenoic Acid) · 729 mg OverallScore81
B+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyB+ Value

The triglyceride form and concentrated EPA content support good absorption and an EPA-focused use. A 729 mg EPA serving is substantial, while molecular distillation provides some purity reassurance without independent certification. Cost efficiency is favorable, though the supplied ingredient details do not show an antioxidant protecting the oil from oxidation.

View ingredientView products
Fish Oil · 1326 mg OverallScore79
B- Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyB+ Value

The triglyceride form and molecular distillation support absorption and purity. The disclosed EPA and DHA provide a standard effective amount in a highly concentrated oil, but no antioxidant stabilizer is listed. Independent testing and fish species are not identified, while the active omega-3 cost is favorable.

View ingredientView products
Omega-3 · 1100 mg OverallScore78
B- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyA+ Value

The triglyceride form and concentrated EPA plus DHA support good absorption and a high active-fatty-acid yield. Separate EPA and DHA amounts make the dose easy to assess, while molecular distillation is disclosed without independent certification or an accessible purity report. The active amount delivered per serving offers favorable value.

View ingredientView products
Loading alternative details
86 Performance

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
A stronger supplied quality profile than Omega-3 Triglyceride Fish Oil 1100 mg is supported by a highly concentrated 1,100 mg triglyceride omega-3 serving with clear EPA and DHA amounts. Molecular distillation adds purity assurance, though fish species, antioxidant protection, and independent testing are not stated.
86 Performance

Purified & Clear Omega 3 Fish Oil 1000 mg

Doctor's Best
A stronger supplied quality profile than Omega-3 Triglyceride Fish Oil 1100 mg is supported by a substantial serving with EPA and DHA stated separately. The ethyl-ester form is less readily absorbed than triglyceride oil, and oxidation protection plus independent testing are not supplied.
85 Performance

Wild Alaskan Fish Oil Peak EPA

Wiley's Finest
A stronger supplied quality profile than Omega-3 Triglyceride Fish Oil 1100 mg is supported by a concentrated EPA-heavy serving with individual fatty-acid amounts clearly stated. Molecular form, oxidation protection, purification, and independent testing remain unspecified.
79 Budget

Fish Oil 1000 mg

Mason Natural
Lower recurring cost is the clearest advantage over Omega-3 Triglyceride Fish Oil 1100 mg, while the formula provides clearly disclosed EPA and DHA in a basic 1,000 mg fish-oil softgel. The active omega-fat amount is low, and source, molecular form, oxidation protection, and purity testing are not supplied.
82 Budget

Omega 3 Fish Oil Concentrate

Solgar
Lower recurring cost is the clearest advantage over Omega-3 Triglyceride Fish Oil 1100 mg, while the formula provides a modest, clearly disclosed EPA and DHA serving for routine use. Low concentration plus missing molecular-form, source, oxidation, and purity details limit quality confidence.
69 Budget

Kid's Chewable DHA 100 mg Bursting Orange Flavor!

Carlson
Lower recurring cost is the clearest advantage over Omega-3 Triglyceride Fish Oil 1100 mg, while the formula provides triglyceride fish oil and vitamin E in a child-friendly chewable with 100 mg DHA. The active omega-3 amount and oil concentration are low, and independent purity testing is not supplied.
84 Value

Omega-3 Fish Oil 1250 mg

SR Sports Research
Lower recurring cost paired with a highly concentrated EPA-led fish-oil serving in one softgel creates a useful value trade-off versus Omega-3 Triglyceride Fish Oil 1100 mg. Molecular form, purification, antioxidant protection, fish species, and independent testing are not supplied.
84 Value

Fish Oil 1400 mg

Nature's Bounty
Lower recurring cost paired with a meaningful EPA-led amount with strong oil concentration creates a useful value trade-off versus Omega-3 Triglyceride Fish Oil 1100 mg. The ethyl-ester form is less readily absorbed, and fish source, antioxidant protection, and independent testing are not stated.
82 Value

Triple Strength Omega-3

InnovixLabs
Lower recurring cost paired with a concentrated mix of EPA, DHA, DPA, and other omega-3 fats in a long supply creates a useful value trade-off versus Omega-3 Triglyceride Fish Oil 1100 mg. Molecular form, purification, fish species, antioxidant protection, and independent testing are missing, and one label row is malformed.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  2. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  3. Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.
    Doshi R; Kumar A; Thakkar S; Shariff M; Adalja D; Doshi A; Taha M; Gupta R; Desai R; Shah J; Gullapalli N · The American journal of cardiology · 2020
    Meta-analysis27,415 participants5 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  4. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
    Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W · European journal of clinical nutrition · 2019
    Meta-analysis3,000 participants51 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  5. Long-Chain Polyunsaturated Fatty Acids Are Associated with Blood Pressure and Hypertension over 10-Years in Black South African Adults Undergoing Nutritional Transition.
    Zec MM; Schutte AE; Ricci C; Baumgartner J; Kruger IM; Smuts CM · Foods (Basel, Switzerland) · 2020
    Cohort study300 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  6. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  7. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  8. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  9. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  10. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  11. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  12. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  13. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  14. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  15. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  16. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  17. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  18. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  19. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  20. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  21. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  22. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  23. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  24. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  25. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  26. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  27. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  28. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    Liu W; Gao M; Yang S; Sun C; Bi Y; Li Y; Wang J; Yuan X · Journal of diabetes and its complications · 2023
    Meta-analysis331 participants6 studies pooledMetabolism Boost forOmega-3
  29. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
    Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L · BMJ open diabetes research & care · 2021
    Randomized trial38 participantsMetabolism Boost forOmega-3
  30. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsMetabolism Boost Skin Health forOmega-3
  31. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2018
    Randomized trial60 participantsMetabolism Boost forOmega-3
  32. A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
    Wang JF; Zhang HM; Li YY; Xia S; Wei Y; Yang L; Wang D; Ye JJ; Li HX; Yuan J; Pan RR · Lipids in health and disease · 2019
    Randomized trial200 participantsMetabolism Boost forOmega-3
  33. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  34. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  35. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  36. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3